Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Inonza 1mg Injection
Inonza 1mg Injection
Manufacturer/Marketed By : PFIZER LTD
$3294.38 $2635.50
Inonza 1mg injection is an anticancer medication with an active ingredient called Inotuzumab ozogamicin. It is used to treat adults with acute lymphoblastic Leukemia. It is intended when patients have...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
INOTUZUMAB OZOGAMICIN
Active Pharmaceutical Ingredient
Inonza 1mg Injection
3294,38 US$
2635,50 US$
Inonza 1mg injection is an anticancer medication with an active ingredient called Inotuzumab ozogamicin. It is used to treat adults with acute lymphoblastic Leukemia. It is intended when patients have failed to respond to other treatments. Acute lymphoblastic Leukemia (ALL) refers to the accumulation of white blood cells that have not matured due to the abnormal production of white blood cells in the bone marrow. Do not take Inonza 1mg injection if you are allergic to Inotuzumab ozogamicin or any other ingredients of this medicine, if you have or have any history with any liver disease, such as venoocculusive disease (damaged liver blood vessels), cirrhosis, nodular regenerative hyperplasia (signs and symptoms of portal hypertension due to chronic use of medicine), or active hepatitis (inflammation of the liver) and blood clot. This medicine is not recommended for children and adolescents. Before starting the Inonza 1mg treatment, inform your doctor if you have signs and symptoms of tumour lysis syndrome, a low number of blood cells (neutrophils), elevations in amylase or lipase enzymes, or a history of QT interval prolongation. Notify your doctor if you are pregnant or planning to get pregnant during and after the treatment for up to 8 months. Use effective contraception during and after eight months of treatment for women and five months for men. Discuss with your doctor for more fertility concerns. Certain tests will be taken to monitor the blood cell count, liver enzyme, and QT interval.
Active Pharmaceutical Ingredient
Usos
• Acute lymphoblastic Leukemia
Beneficios
Inotuzumab ozogamicin in Inonza 1mg injection targets a protein called CD22, which is commonly expressed by blood cancer (ALL) cells. After attaching to this protein, this medicine disturbs the DNA of the cancer cells and eventually kills them.
Efectos secundarios
Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.
Efectos secundarios más comunes
• Anaemia
• Tiredness
• Infection
• Bleeding
• Fever
• Nausea
• Headache
• Abnormal blood values
• Stomach pain
• High bilirubin value
• Low appetite
• Mouth inflammation
• Constipation
• Diarrhea
• Swelling of abdomen
Efectos secundarios comunes
• Breathing trouble
• Chills
• Rapid weight gain
• Abnormal liver function values
• Frequent bleeding and bruising
• Infusion-related reaction (fever, chill, breathing trouble)
• Venoocclusive liver disease (rapid weight gain, right upper abdomen pain, swelling of the liver)
• The lower number of blood cells
• Tumor lysis syndrome
• Changes in the electrical activity of the heart
Cómo utilizar
A trained doctor or nurse should only administer it. Do not self-administer the Inonza 1mg injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects.
Consejos de seguridad
• Breast Feeding: It is unsafe to take Inonza 1mg Injection while breastfeeding. Before starting the treatment, notify your doctor if you are breastfeeding. Do not breastfeed during and at least after the two months of the last dose.
• Alcohol: It is unknown whether it is safe to consume alcohol with Inonza 1mg Injection as this medicine makes you feel drowsy. Please consult your doctor for more information.
• Liver: Inform your physician about any underlying liver disorders before taking Inonza 1mg Injection, as this medication should be used cautiously in liver disease patients. Consult your physician before taking this medicine.
• Lungs: It is unknown whether Inonza 1mg Injection is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: Driving while taking Inonza 1mg Injection is unsafe because this medicine might tire you. So, avoid driving and operating machinery during this treatment.
• Pregnancy: Your doctor will prescribe Inonza 1mg Injection only if needed, as this medicine might cause harm to the unborn baby. So notify your doctor before starting the preganat if you are preganat or planning to get pregnant. It is advised for women to use contraception during and after the treatment for at least eight months.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.